Moleculin Biotech

-$0.01 (-0.31%) As of 5:27 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.

About MBRX

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which engages in the development of treatments for highly resistant cancers and viruses. Its clinical stage drugs include Annamycin, an Anthracycline being studied for the treatment of relapsed or refractory acute myeloid leukemia (AML); and WP1066, an Immune/Transcription Modulator targeting brain tumors, pancreatic cancer, and AML.

CEO
Walter V. Klemp
Employees
15
Headquarters
Houston, Texas
Founded
2015

MBRX Key Statistics

Market Cap
110.71M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
232.69K
High Today
$3.24
Low Today
$3.17
Open Price
$3.17
Volume
31.97K
52 Week High
$8.78
52 Week Low
$3.10

MBRX Earnings

-$0.20
-$0.13
-$0.07
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure